Insider · CIK 0001692929

SCHAFFER DAVID

Reports to the SEC for 2 companies · AMSTERDAM, P7

sec.gov

Transactions

Companies

Filings

CIK

0001692929

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-10-22	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−1,900 sh	$31.00	−$58.9K	901,215
2021-10-21	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−22.8K sh	$31.56	−$720K	903,115
2021-10-20	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−11.6K sh	$31.02	−$359K	925,935
2021-09-30	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−7,836 sh	$26.69	−$209K	942,049
2021-09-30	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−4,549 sh	$27.28	−$124K	937,500
2021-09-29	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−7,806 sh	$27.99	−$219K	958,950
2021-09-29	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−8,365 sh	$29.06	−$243K	950,585
2021-09-29	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−700 sh	$30.06	−$21K	949,885
2021-09-28	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−13.8K sh	$30.52	−$421K	966,856
2021-09-28	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$32.00	−$3,200	966,756
2021-09-27	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−13.1K sh	$32.59	−$426K	986,925
2021-09-27	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−6,157 sh	$33.51	−$206K	980,768
2021-09-27	FDMT4D Molecular Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$34.19	−$3,419	980,668
2021-05-17	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2020-02-27	QUREuniQure N.V.A Award	Director	AAward	−2,063 sh	—	—	46,978
2020-02-27	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	Director	AAward	+3,620 sh	—	—	3,620
2020-01-28	QUREuniQure N.V.S Sale	Director	SSale	−806 sh	$62.27	−$50.2K	44,915
2019-01-28	QUREuniQure N.V.S Sale	Director	SSale	−1,210 sh	$31.31	−$37.9K	45,721
2019-01-25	QUREuniQure N.V.A Award	Director	AAward	+3,230 sh	—	—	46,931
2019-01-25	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	Director	AAward	+5,295 sh	—	—	5,295
2019-01-17	QUREuniQure N.V.S Sale	Director	SSale	−7,500 sh	$30.71	−$230K	43,701
2018-01-29	QUREuniQure N.V.S Sale	Director	SSale	−2,878 sh	$18.53	−$53.3K	15,314
2018-01-26	QUREuniQure N.V.A Award	Director	AAward	+4,792 sh	—	—	18,192
2018-01-26	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	Director	AAward	+6,390 sh	—	—	6,390
2017-01-27	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2017-01-27	QUREuniQure N.V. · Restricted Stock UnitsA Award	Director	AAward	+11K sh	—	—	16,000

Recent filings

Accepted (ET)
Oct 224
SCHAFFER DAVID0001567619-21-018628
SEC(opens sec.gov)
Oct 14
SCHAFFER DAVID0001567619-21-017751
SEC(opens sec.gov)
Sep 294
SCHAFFER DAVID0001567619-21-017624
SEC(opens sec.gov)
May 194
SCHAFFER DAVID0001567619-21-010750
SEC(opens sec.gov)
Mar 24
SCHAFFER DAVID0000904454-20-000257
SEC(opens sec.gov)
Jan 304
SCHAFFER DAVID0000904454-20-000112
SEC(opens sec.gov)
Jan 304
SCHAFFER DAVID0000904454-19-000130
SEC(opens sec.gov)
Jan 294
SCHAFFER DAVID0000904454-19-000109
SEC(opens sec.gov)

Companies

Address

C/O UNIQURE N.V. MEIBERGDREFF 61

AMSTERDAM, P7, 1005 BA